William Blair Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-332,923
Closed -$30.5M 444
2021
Q2
$30.5M Sell
332,923
-13,443
-4% -$1.07M 0.1% 178
2021
Q1
$23.6M Sell
346,366
-69,055
-17% -$5.36M 0.08% 200
2020
Q4
$30.1M Sell
415,421
-105,194
-20% -$6.1M 0.1% 169
2020
Q3
$19.8M Buy
520,615
+277,658
+114% +$9.37M 0.08% 193
2020
Q2
$8.61M Buy
+242,957
New +$6.91M 0.04% 265
2020
Q1
Sell
-359,854
Closed -$7.76M 346
2019
Q4
$7.76M Buy
359,854
+81,637
+29% +$1.87M 0.03% 308
2019
Q3
$6.29M Buy
278,217
+14,883
+6% +$412K 0.03% 310
2019
Q2
$9.48M Buy
+263,334
New +$8.43M 0.04% 316

Other funds holding CDNA

William Blair Investment Management's CDNA Position: Q3 2021 in Review

William Blair Investment Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 332,923 shares — an estimated $30.5M sold.

William Blair Investment Management first reported a position in CDNA in Q2 2019 and held it in 8 quarters. The position peaked at $30.5M in Q2 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • William Blair Investment Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • William Blair Investment Management sold 332,923 CareDx shares in Q3 2021, an estimated $30.5M.
  • William Blair Investment Management first reported a position in CareDx in Q2 2019 and held it in 8 quarters.
  • William Blair Investment Management's CareDx position peaked at $30.5M in Q2 2021.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on William Blair Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.